Vicore Pharma Holding
18,6 SEK -0,53%2 investorer følger denne virksomhed
Vicore Pharma Holding is a pharmaceutical company. The company conducts research and development of molecules with agnostic effect, in industry terms called Renin-Angiotensin System (RAS), which affects the fluid and salt balance in the body. Vicore Pharma usually enters into licensing agreements with other pharmaceutical partners in the industry and has business operations at a global level. The company was founded in 2000 and is headquartered in Gothenburg.
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
VICO
Daglig lav / høj pris
18,54 / 18,98
SEK
Markedsværdi
2,08 mia. SEK
Aktieomsætning
879,26 t SEK
Volumen
47 t
Seneste videoer
Finanskalender
Delårsrapport
22.08.2024
Delårsrapport
05.11.2024
Årsrapport
27.02.2025
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
HealthCap VII L.P. | 16,5 % | 16,5 % |
Fjärde AP-fonden | 9,8 % | 9,8 % |
Premium
This content is for our Premium customers only.
ViserAlle indholdstyper
Vicore Pharma, Webcast, 2024
Vicore Announces Positive Final Results from the Phase 2a AIR Trial Demonstrating Buloxibutid Improves Lung Function Over 36 Weeks in Patients with Idiopathic Pulmonary Fibrosis
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools